Events

« All Events

JP Morgan Healthcare Conference 2026

January 12, 2026 - January 15, 2026

Join us at Hilton San Francisco Union Square, San Francisco, CA

January 12 – 15, 2026

If you are attending the JP Morgan Healthcare Conference in San Francisco this January, we would love to connect with you!

Avid Bioservices brings decades of experience in biologics development and manufacturing, supporting innovators from early-stage development through commercial production. Whether you’re scaling up a complex biologic of redefining your process, our team is ready to explore how our tailored CDMO solutions can support your goals.

 

 

Why Meet with Avid Bioservices?

• 30+ years of biologics development experience
• Flexible CDMO services from clinical to commercial production
• Unparalleled quality and operational excellence
• Best-in-class U.S.-based facilities
• We approach every customer and molecule with personalized care
• Onshoring with a U.S.-based CDMO reduces supply chain risks and helps navigate global tariffs

 

Meet Our Experts

Our team will be onsite to discuss:

• Process development and scale-up for biologics
• Upstream and downstream optimization strategies
• Analytical characterization and QC for complex biologics
• CGMP manufacturing for clinical and commercial supply
• How onshoring can enhance supply chain resilience and reduce geopolitical risk

 

Add to calendar

• Google Calendar
• iCalendar
• Outlook 365
• Outlook Live

Details

Start:

January 12, 2026

End:

January 15, 2026

Event Category:

Conference

Venue

Hilton San Francisco Union Square

333 O'Farrell St
San Francisco, CA 94102 United States

Related Events

• 

  The Secret Batch Happy Hour

  December 10 @ 5:00 pm - 8:00 pm

News

• Avid Bioservices appoints Dave Stewart as Chief Technology and Transformation Officer

  October 7, 2025

  The newly created role marks a major step in CEO Kenneth Bilenberg’s vision to scale Avid for its next chapter of growth.    TUSTIN, Calif., November 10, 2025 – Avid […]

  Read more

• Avid Bioservices Welcomes Kenneth Bilenberg as New CEO

  September 15, 2025

  Tustin, CA, USA – September 15, 2025 – Avid Bioservices, Inc., a leading biologics contract development and manufacturing organization (CDMO), today announced the appointment of Kenneth Bilenberg as its new […]

  Read more

• CHO Plus Enters into Project Agreement with BARDA’s BioMaP Consortium to Develop High Productivity Cell Lines for Filovirus Monoclonal Antibody Production

  August 5, 2025

  SOUTH SAN FRANCISCO, California – August 05, 2025 – Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical […]

  Read more

• GHO & Ampersand Complete Acquisition of Avid Bioservices

  February 5, 2025

  Download PDF Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners Acquisition of biologics Contract Development and Manufacturing Organisation Avid Bioservices now completed GHO […]

  Read more

• Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger

  February 5, 2025

  Download PDFAvid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger TUSTIN, Calif., February 5, 2025 — Avid […]

  Read more

• Avid Stockholders Approve Transaction with GHO and Ampersand

  January 30, 2025

  Download PDFTUSTIN, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve […]

  Read more

< View Older News